Status:
COMPLETED
AESCULAP® Plasmafit® Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polyethylene
Lead Sponsor:
Federal State Budgetary Organization, Federal Center for Traumatology, Orthopedics and Arthroplasty
Conditions:
Osteoarthritis, Hip
Rheumatic Arthritis
Eligibility:
All Genders
18-55 years
Brief Summary
Objectives of this study is evaluate effectivness of AESCULAP® Plasmafit® Plasmafit Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polyethylene compare to the sane...
Detailed Description
Osteoarthritis is one most common disease in aged population, that most advanced stage needs surgical treatment. Surgical treatment usually include installation of implants. Every year new types of im...
Eligibility Criteria
Inclusion
- All patients who needs total knee replacement surgery
- Informed consent from the patients.
Exclusion
- \-
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05291130
Start Date
August 1 2020
End Date
August 1 2022
Last Update
July 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal Center for Traumatology, Orthopedics and Endoprosthetics
Cheboksary, Chuvashskaya Respublika, Russia, 429500